A-Alpha Bio

company

About

A-Alpha Bio is a provider of cell-based tools for quantitative and high-throughput measurements of protein interactions.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$256K
Industries
Biotechnology,Health Care,Product Design
Founded date
Jan 1, 2017
Number Of Employee
11 - 50
Operating Status
Active

A-Alpha Bio provides cell-based tools for quantitative and high-throughput measurements of protein interactions, accelerating target discovery, library screening, and preclinical drug characterization. A-Alpha Bio's product, AlphaSeq, is a revolutionary cell-based platform technology that will fundamentally change the way that protein interactions are measured.

A-Alpha Bio is a team of synthetic biologists, structural biologists, and next-generation sequencing experts who have come together to remove this industry-wide bottleneck.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$481K
A-Alpha Bio has raised a total of $481K in funding over 2 rounds. Their latest funding was raised on Sep 1, 2020 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 1, 2020 Grant $256K 1 National Science Foundation Detail
Jul 24, 2018 Grant $225K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
A-Alpha Bio is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant